4TO fundamentals
An in-depth look to MAINZ BIOMED N.V. operating, investing, and financing activities
4TO free cash flow for Q4 23 is -4.36 M EUR. For 2023, 4TO free cash flow was -20.96 M EUR and operating cash flow was -19.88 M EUR.
Q1 '21
Q2 '21
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '21
Q2 '21
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM